134 related articles for article (PubMed ID: 1438498)
1. Failure of cholecystokinin antagonists to modify the discriminative stimulus effects of cocaine.
Spealman RD
Pharmacol Biochem Behav; 1992 Oct; 43(2):613-6. PubMed ID: 1438498
[TBL] [Abstract][Full Text] [Related]
2. Effects of cholecystokinin antagonists on the discriminative stimulus effects of cocaine in rats and monkeys.
Massey BW; Vanover KE; Woolverton WL
Drug Alcohol Depend; 1994 Jan; 34(2):105-11. PubMed ID: 8026297
[TBL] [Abstract][Full Text] [Related]
3. The CCKA receptor antagonist devazepide does not modify opioid self-administration or drug discrimination: comparison with the dopamine antagonist haloperidol.
Higgins GA; Joharchi N; Wang Y; Corrigall WA; Sellers EM
Brain Res; 1994 Mar; 640(1-2):246-54. PubMed ID: 8004452
[TBL] [Abstract][Full Text] [Related]
4. Discriminative stimulus effects of cocaine in squirrel monkeys: lack of antagonism by the dopamine D2 partial agonists terguride, SDZ 208-911, and SDZ 208-912.
Spealman RD
Pharmacol Biochem Behav; 1995 Aug; 51(4):661-5. PubMed ID: 7675840
[TBL] [Abstract][Full Text] [Related]
5. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
Boyle SJ; Tang KW; Woodruff GN; McKnight AT
Br J Pharmacol; 1993 Aug; 109(4):913-7. PubMed ID: 8401944
[TBL] [Abstract][Full Text] [Related]
6. Several roles of CCKA and CCKB receptor subtypes in CCK-8-induced and LiCl-induced taste aversion conditioning.
Mosher JT; Johnson MF; Birkemo LS; Ervin GN
Peptides; 1996; 17(3):483-8. PubMed ID: 8735976
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of the cholecystokinin-B receptor antagonist, PD 134308, and the cholecystokinin-A receptor antagonist, L-364,718, on dopamine neuronal activity in the substantia nigra and ventral tegmental area.
Meltzer LT; Christoffersen CL; Serpa KA; Razmpour A
Synapse; 1993 Feb; 13(2):117-22. PubMed ID: 8446920
[TBL] [Abstract][Full Text] [Related]
8. Receptor mediation of the stimulus properties of cholecystokinin.
Melton PM; Riley AL
Pharmacol Biochem Behav; 1994 May; 48(1):275-9. PubMed ID: 8029299
[TBL] [Abstract][Full Text] [Related]
9. Blockade of the discriminative stimulus effects of cocaine in rhesus monkeys with the D1 dopamine antagonist SCH 23390.
Kleven MS; Anthony EW; Goldberg LI; Woolverton WL
Psychopharmacology (Berl); 1988; 95(3):427-9. PubMed ID: 2901130
[TBL] [Abstract][Full Text] [Related]
10. Cholecystokinin A receptor antagonist inhibits feed memory in Japanese quail.
Berthelot V; Belzung C; Meunier-Salaun MC; Nowak R; Picard M
Physiol Behav; 1996 Aug; 60(2):575-9. PubMed ID: 8840921
[TBL] [Abstract][Full Text] [Related]
11. Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway.
Crawley JN
J Neurosci; 1992 Sep; 12(9):3380-91. PubMed ID: 1527584
[TBL] [Abstract][Full Text] [Related]
12. Discriminative stimulus effects of cocaine: antagonism by dopamine D1 receptor blockade in the amygdala.
Callahan PM; Bryan SK; Cunningham KA
Pharmacol Biochem Behav; 1995 Aug; 51(4):759-66. PubMed ID: 7675856
[TBL] [Abstract][Full Text] [Related]
13. Serotonin 5-HT3 antagonists do not alter the discriminative stimulus properties of cocaine.
Paris JM; Cunningham KA
Psychopharmacology (Berl); 1991; 104(4):475-8. PubMed ID: 1780417
[TBL] [Abstract][Full Text] [Related]
14. Devazepide, a CCKA receptor antagonist, impairs the acquisition of conditioned reward and conditioned activity.
Josselyn SA; Franco VP; Vaccarino FJ
Psychopharmacology (Berl); 1996 Jan; 123(2):131-43. PubMed ID: 8741936
[TBL] [Abstract][Full Text] [Related]
15. His381 of the rat CCKB receptor is essential for CCKB versus CCKA receptor antagonist selectivity.
Jagerschmidt A; Guillaume-Rousselet N; Vikland ML; Goudreau N; Maigret B; Roques BP
Eur J Pharmacol; 1996 Jan; 296(1):97-106. PubMed ID: 8720482
[TBL] [Abstract][Full Text] [Related]
16. Modulatory role for CCK-B antagonists in Parkinson's disease.
Boyce S; Rupniak NM; Tye S; Steventon MJ; Iversen SD
Clin Neuropharmacol; 1990 Aug; 13(4):339-47. PubMed ID: 1976438
[TBL] [Abstract][Full Text] [Related]
17. An investigation into the discriminative stimulus and reinforcing properties of the CCKB-receptor antagonist, L-365,260 in rats.
Jackson A; Tattersall D; Bentley G; Rycroft W; Bourson A; Hargreaves R; Tricklebank M; Iversen S
Neuropeptides; 1994 May; 26(5):343-53. PubMed ID: 8065550
[TBL] [Abstract][Full Text] [Related]
18. The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
Singh L; Field MJ; Hughes J; Menzies R; Oles RJ; Vass CA; Woodruff GN
Br J Pharmacol; 1991 Sep; 104(1):239-45. PubMed ID: 1686205
[TBL] [Abstract][Full Text] [Related]
19. Hypolocomotion induced by peripheral or central injection of CCK in the mouse is blocked by the CCKA receptor antagonist devazepide but not by the CCKB receptor antagonist L-365,260.
O'Neill MF; Dourish CT; Iversen SD
Eur J Pharmacol; 1991 Feb; 193(2):203-8. PubMed ID: 2050197
[TBL] [Abstract][Full Text] [Related]
20. Opioid enhancement of the discriminative stimulus effects of cocaine: evidence for involvement of mu and delta opioid receptors.
Rowlett JK; Spealman RD
Psychopharmacology (Berl); 1998 Nov; 140(2):217-24. PubMed ID: 9860113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
